Juan José Lasarte is an expert in Immunology at Clinica Universidad de Navarra (Spain). Juan José Lasarte has authored 266 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 763 (community average: 125). How the SLR is computed.

LeadR Profile

Juan José Lasarte Clinica Universidad de Navarra Spain
763 ScienceLeadR Reputation 763
Network Map

Immunology

Subspecialties: Hematology - Oncology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026

Source: PubMed

University of Navarra

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 266

Citations

Citations: 9 141 1st author: 12 Last author: 40 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Impact of supervised physical exercise on inflammatory and oxidative stress biomarkers in older adults: a systematic review and meta-analysis of randomized controlled trials.
PMID 42786581 — exercise, stress, physiological, oxidative stress, biomarkers, geriatrics
Gerontologist20260
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.
PMID 42101964 — cells, genes, hematology, pharmaceutical preparations, therapeutics, t-lymphocytes
Blood20260
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma.
PMID 42027747 — cells, multiple myeloma, therapeutics, clone cells, t-lymphocytes, interleukin-10, car-t cell
Blood Neoplasia20260
Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas.
PMID 42010569 — lymphoma, neoplasms, therapeutics
Mol Cancer Top journal20260
Correction: Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy.
PMID 41678278 — cells, drug therapy, interleukin-17, chemotherapy
J Exp Med20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map